加载中
HKSEHealthcareDrug Manufacturers - Specialty & Generic
最新数据
HK$0.241
HK$0.00 · -0.41%
PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.
最新数据
HK$0.241
HK$0.00 · -0.41%
PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.
日内区间
当前HK$0.241
52周区间
当前HK$0.241
历史价格可能经过调整并有所延迟。
PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.
日内区间
当前HK$0.241
52周区间
当前HK$0.241
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（HKD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3.36亿 HKD | 3.82亿 HKD | 4.07亿 HKD | 4.48亿 HKD | 6.6亿 HKD |
| 销货成本 | 1.56亿 HKD | 1.77亿 HKD | 1.9亿 HKD | 1.87亿 HKD | 2.38亿 HKD |
| 毛利 | 1.8亿 HKD | 2.05亿 HKD | 2.17亿 HKD | 2.61亿 HKD | 4.22亿 HKD |
| 研究与开发 | 1376.3万 HKD | 1116.8万 HKD | 1498.7万 HKD | 2232.3万 HKD | 2395万 HKD |
| 销售、一般及管理费用 | 2.05亿 HKD | 2.23亿 HKD | 2.63亿 HKD | 3.26亿 HKD | 3.8亿 HKD |
| 营业费用 | 2.1亿 HKD | 2.35亿 HKD | 2.83亿 HKD | 3.25亿 HKD | 4.04亿 HKD |
| 利息收入 | 3.9万 HKD | 34.9万 HKD | 29.3万 HKD | 47.5万 HKD | 36万 HKD |
| 利息支出 | 2072.2万 HKD | 2371.4万 HKD | 2740.7万 HKD | 2418.3万 HKD | 2702.7万 HKD |
| 折旧和摊销 | 4452.6万 HKD | 5466.6万 HKD | 4859.1万 HKD | 4866.1万 HKD | 5013.9万 HKD |
| 营业利润 | −2998.5万 HKD | −2941.5万 HKD | −5158.3万 HKD | −6450万 HKD | 1761.8万 HKD |
| 净利润 | −3522.3万 HKD | −3543.9万 HKD | −1.06亿 HKD | −1.2亿 HKD | −1.22亿 HKD |
公司数据更新于 2026年10月17日。
近期已公布业绩
近期已公布业绩
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。